Gastroenterology News

Each January, Alcohol Change UK runs Dry January, a post-holiday campaign that encourages people to abstain from alcohol for 31 days at the beginning of the year and drink more healthily year-round.

Glucagon-like peptide 1 receptor agonists significantly lowered the risk for colorectal cancer in patients with type 2 diabetes compared with other diabetes medications, according to a research letter in JAMA Oncology.

The incorporation of low-dose esketamine to propofol-based sedation reduced desaturation and hypotension events by approximately 61% among patients undergoing same-visit bidirectional endoscopy, researchers reported.

Facility fees for three common colonoscopy procedures were approximately 55% higher at hospitals compared with ambulatory surgery centers in the same county and with the same insurer, researchers reported in JAMA Health Forum.

“Why should I be investing in bonds when I can earn more than 5% on my cash?” Many investors, including physicians, are asking this question after being discouraged by losses they have experienced with bonds in recent years.

Older adult patients with acute-on-chronic liver failure had significantly higher waitlist mortality but “acceptable” 1-year survival after liver transplantation, according to data in Clinical Gastroenterology and Hepatology.

BOSTON — Residents who learn to screen and treat patients for hepatitis C virus infection in a primary care setting reported feeling more comfortable prescribing treatment, with improved screening rates reported, according to a poster.

The introduction of biologics as a therapeutic option for Crohn’s disease had “only a slight impact” on eventual surgery occurrence, although it may delay the first intestinal resection compared with conventional therapy, data showed.

Results of a phase 1 trial for a vaccine targeting micrometastatic disease markers in patients already treated for pancreatic or colorectal cancer showed potential in preventing recurrence, according to a study in Nature Medicine.

Patients with cirrhosis are less frequently screened for osteoporosis compared with the general population, and less than 25% with low bone density actually receive treatment, according to research in Alimentary Pharmacology & Therapeutics.